Drug recall · May 8, 2013
Femhrt (norethindrone acetate and ethinyl estradiol) tablets recall
Why: Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Femhrt (norethindrone acetate and ethinyl estradiol) tablets, 0.5 mg/2.5 mcg, 90 count bottle (NDC#: 0430-0145-23), Rx only, Manufactured by Warner Chilcott Company, LLC, Fajardo, PR 00738, Marketed by Warner Cholcott (US), LLC, Rockaway, NJ 07866
- Lots / codes
Lot# 510122B; exp 04/13
- Quantity
- 27,509 bottles
- Company
- Warner Chilcott Company LLC, Fajardo, PR
- Distribution
- US Nationwide and Puerto Rico
- Initiated
- February 15, 2013 · Voluntary: Firm initiated
- Classified
- April 30, 2013
- Reported
- May 8, 2013
- Ended
- June 9, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.